|
1
|
Spira A and Ettinger DS: Multidisciplinary
management of lung cancer. N Engl J Med. 350:379–392. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mercier O, Fadel E, de Perrot M, Mussot S,
Stella F, Chapelier A and Dartevelle P: Surgical treatment of
solitary adrenal metastasis from non-small cell lung cancer. J
Thorac Cardiovasc Surg. 130:136–140. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo H, Ingolia NT, Weissman JS and Bartel
DP: Mammalian microRNAs predominantly act to decrease target mRNA
levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boeri M, Sestini S, Fortunato O, Verri C,
Suatoni P, Pastorino U and Sozzi G: Recent advances of
microRNA-based molecular diagnostics to reduce false-positive lung
cancer imaging. Expert Rev Mol Diagn. 15:801–813. 2015.PubMed/NCBI
|
|
7
|
Skrzypski M, Dziadziuszko R and Jassem J:
MicroRNA in lung cancer diagnostics and treatment. Mutat Res.
717:25–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guan P, Yin Z, Li X, Wu W and Zhou B:
Meta-analysis of human lung cancer microRNA expression profiling
studies comparing cancer tissues with normal tissues. J Exp Clin
Cancer Res. 31:542012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shang Y, Zang A, Li J, Jia Y, Li X, Zhang
L, Huo R, Yang J, Feng J, Ge K, et al: MicroRNA-383 is a tumor
suppressor and potential prognostic biomarker in human non-small
cell lung cancer. Biomed Pharmacother. 83:1175–1181. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeng Y, Zhu J, Shen D, Qin H, Lei Z, Li W,
Liu Z and Huang JA: MicroRNA-205 targets SMAD4 in non-small cell
lung cancer and promotes lung cancer cell growth in vitro and in
vivo. Oncotarget. Jun 30–2016.Epub ahead of print.
|
|
11
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mahmood MQ, Ward C, Muller HK, Sohal SS
and Walters EH: Epithelial mesenchymal transition (EMT) and
non-small cell lung cancer (NSCLC): A mutual association with
airway disease. Med Oncol. 34:452017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qin Q, Wei F, Zhang J and Li B: miR-134
suppresses the migration and invasion of non-small cell lung cancer
by targeting ITGB1. Oncol Rep. 37:823–830. 2017.PubMed/NCBI
|
|
14
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hao J, Zhang Y, Deng M, Ye R, Zhao S, Wang
Y, Li J and Zhao Z: MicroRNA control of epithelial-mesenchymal
transition in cancer stem cells. Int J Cancer. 135:1019–1027. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu M, Xue H, Wang Y, Shen Q, Jiang Q,
Zhang X, Li K, Jia M, Jia J, Xu J, et al: miR-345 inhibits tumor
metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT
pathway in hepatocellular carcinoma. Int J Oncol. 50:975–983.
2017.PubMed/NCBI
|
|
17
|
Sathyanarayanan A, Chandrasekaran KS and
Karunagaran D: microRNA-145 modulates epithelial-mesenchymal
transition and suppresses proliferation, migration and invasion by
targeting SIP1 in human cervical cancer cells. Cell Oncol (Dordr).
40:119–131. 2017. View Article : Google Scholar
|
|
18
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol Chem.
283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Korpal M and Kang Y: The emerging role of
miR-200 family of microRNAs in epithelial-mesenchymal transition
and cancer metastasis. RNA Biol. 5:115–119. 2008. View Article : Google Scholar
|
|
20
|
Song CL, Liu B, Shi YF, Liu N, Yan YY,
Zhang JC, Xue X, Wang JP, Zhao Z, Liu JG, et al: MicroRNA-130a
alleviates human coronary artery endothelial cell injury and
inflammatory responses by targeting PTEN via activating
PI3K/Akt/eNOS signaling pathway. Oncotarget. 7:71922–71936.
2016.PubMed/NCBI
|
|
21
|
Fukumoto I, Kinoshita T, Hanazawa T,
Kikkawa N, Chiyomaru T, Enokida H, Yamamoto N, Goto Y, Nishikawa R,
Nakagawa M, et al: Identification of tumour suppressive
microRNA-451a in hypopharyngeal squamous cell carcinoma based on
microRNA expression signature. Br J Cancer. 111:386–394. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
da Silva Xavier G, Leclerc I, Varadi A,
Tsuboi T, Moule SK and Rutter GA: Role for AMP-activated protein
kinase in glucose-stimulated insulin secretion and preproinsulin
gene expression. Biochem J. 371:761–774. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng H and Kang Y: Multilayer control of
the EMT master regulators. Oncogene. 33:1755–1763. 2014. View Article : Google Scholar
|
|
24
|
Zhang G, Zhou H, Xiao H, Liu Z, Tian H and
Zhou T: MicroRNA-92a functions as an oncogene in colorectal cancer
by targeting PTEN. Dig Dis Sci. 59:98–107. 2014. View Article : Google Scholar
|
|
25
|
Zhang JX, Zhai JF, Yang XT and Wang J:
MicroRNA-132 inhibits migration, invasion and
epithelial-mesenchymal transition by regulating TGFβ1/Smad2 in
human non-small cell lung cancer. Eur Rev Med Pharmacol Sci.
20:3793–3801. 2016.PubMed/NCBI
|
|
26
|
Lamouille S, Subramanyam D, Blelloch R and
Derynck R: Regulation of epithelial-mesenchymal and
mesenchymal-epithelial transitions by microRNAs. Curr Opin Cell
Biol. 25:200–207. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xiao J, Hu CP, He BX, Chen X, Lu XX, Xie
MX, Li W, He SY, You SJ and Chen Q: PTEN expression is a prognostic
marker for patients with non-small cell lung cancer: A systematic
review and meta-analysis of the literature. Oncotarget.
7:57832–57840. 2016.PubMed/NCBI
|
|
28
|
Gu J, Ou W, Huang L, Wu J, Li S, Xu J,
Feng J, Liu B and Zhou Y: PTEN expression is associated with the
outcome of lung cancer: Evidence from a meta-analysis. Minerva Med.
107:342–351. 2016.PubMed/NCBI
|
|
29
|
Zhu DY, Li XN, Qi Y, Liu DL, Yang Y, Zhao
J, Zhang CY, Wu K and Zhao S: MiR-454 promotes the progression of
human non-small cell lung cancer and directly targets PTEN. Biomed
Pharmacother. 81:79–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chetram MA and Hinton CV: PTEN regulation
of ERK1/2 signaling in cancer. J Recept Signal Transduct Res.
32:190–195. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Feng X, Jiang J, Shi S, Xie H, Zhou L and
Zheng S: Knockdown of miR-25 increases the sensitivity of liver
cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad
signaling pathway. Int J Oncol. 49:2600–2610. 2016.PubMed/NCBI
|
|
32
|
Xia H, Li Y and Lv X: MicroRNA-107
inhibits tumor growth and metastasis by targeting the BDNF-mediated
PI3K/AKT pathway in human non-small lung cancer. Int J Oncol.
49:1325–1333. 2016.PubMed/NCBI
|
|
33
|
Wang R, Zhang Q, Peng X, Zhou C, Zhong Y,
Chen X, Qiu Y, Jin M, Gong M and Kong D: Stellettin B induces G1
arrest, apoptosis and autophagy in human non-small cell lung cancer
A549 cells via blocking PI3K/Akt/mTOR pathway. Sci Rep.
6:270712016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: Role
of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene.
24:7443–7454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xiao L, Zhou H, Li XP, Chen J, Fang C, Mao
CX, Cui JJ, Zhang W, Zhou HH, Yin JY, et al: MicroRNA-138 acts as a
tumor suppressor in non small cell lung cancer via targeting YAP1.
Oncotarget. 7:40038–40046. 2016.PubMed/NCBI
|
|
36
|
Pastorkova Z, Skarda J and Andel J: The
role of microRNA in metastatic processes of non-small cell lung
carcinoma. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub.
160:343–357. 2016.PubMed/NCBI
|
|
37
|
Zhang Y, Xu X, Zhang M, Wang X, Bai X, Li
H, Kan L, Zhou Y, Niu H and He P: MicroRNA-663a is downregulated in
non-small cell lung cancer and inhibits proliferation and invasion
by targeting JunD. BMC Cancer. 16:3152016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen W, Wang J, Liu S, Wang S, Cheng Y,
Zhou W, Duan C and Zhang C: MicroRNA-361-3p suppresses tumor cell
proliferation and metastasis by directly targeting SH2B1 in NSCLC.
J Exp Clin Cancer Res. 35:762016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gong F, Ren P, Zhang Y, Jiang J and Zhang
H: MicroRNAs-491-5p suppresses cell proliferation and invasion by
inhibiting IGF2BP1 in non-small cell lung cancer. Am J Transl Res.
8:485–495. 2016.PubMed/NCBI
|
|
40
|
Ren P, Gong F, Zhang Y, Jiang J and Zhang
H: MicroRNA-92a promotes growth, metastasis, and chemoresistance in
non-small cell lung cancer cells by targeting PTEN. Tumour Biol.
37:3215–3225. 2016. View Article : Google Scholar
|
|
41
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zaravinos A: The regulatory role of
microRNAs in EMT and cancer. J Oncol. 2015:8658162015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Stinson S, Lackner MR, Adai AT, Yu N, Kim
HJ, O'Brien C, Spoerke J, Jhunjhunwala S, Boyd Z, Januario T, et
al: miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1)
promotes epithelial-to-mesenchymal transition in breast cancer. Sci
Signal. 4:pt52011.PubMed/NCBI
|
|
44
|
Zhang Z, Liu S, Shi R and Zhao G: miR-27
promotes human gastric cancer cell metastasis by inducing
epithelial-to-mesenchymal transition. Cancer Genet. 204:486–491.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Castellino RC and Durden DL: Mechanisms of
disease: The PI3K-Akt-PTEN signaling node - an intercept point for
the control of angiogenesis in brain tumors. Nat Clin Pract Neurol.
3:682–693. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Grille SJ, Bellacosa A, Upson J,
Klein-Szanto AJ, van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN and
Larue L: The protein kinase Akt induces epithelial mesenchymal
transition and promotes enhanced motility and invasiveness of
squamous cell carcinoma lines. Cancer Res. 63:2172–2178.
2003.PubMed/NCBI
|
|
47
|
Vogt PK, Gymnopoulos M and Hart JR: PI
3-kinase and cancer: Changing accents. Curr Opin Genet Dev.
19:12–17. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tu K, Liu Z, Yao B, Han S and Yang W:
MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT
signaling in hepatocellular carcinoma. Int J Oncol. 48:965–974.
2016.
|
